Immunotherapy for infectious diseases represents a cutting-edge approach to combatting microbial pathogens by harnessing the body's immune system. Unlike traditional antimicrobial agents, which directly target pathogens, immunotherapy focuses on bolstering the host's immune response to better eliminate invading microbes. This strategy involves various interventions, including vaccines, monoclonal antibodies, and immune modulators, designed to enhance the body's ability to recognize and neutralize infectious agents. For instance, vaccines stimulate the production of pathogen-specific antibodies and memory T-cells, providing long-term protection against future infections. Similarly, monoclonal antibodies can directly target and neutralize microbial toxins or virulence factors, mitigating disease severity. By leveraging the power of immunotherapy, researchers aim to develop novel strategies for preventing and treating a wide range of infectious diseases, potentially revolutionizing the field of infectious disease management.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Gendered socioeconomic impacts of emerging infectious diseases: Insights from a mixed-methods study in Guinea
Stephanie Maltais, University of Montreal, Canada
Title : The role of social sciences in operationalizing the One Health approach: A case study of the DOPERAUS project in Guinea and the Democratic Republic of Congo
Stephanie Maltais, University of Montreal, Canada